Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.49 SEK | 0.00% | -0.71% | -6.31% |
Apr. 16 | Mendus AB Announces Board Changes | CI |
Mar. 27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
- Stock Market
- Equities
- IMMU Stock
- News Mendus AB